Sign in
8-K

Current Report

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001140361-25-024089

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading ef20051351_8k.htm…